This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fierens, F. L. Articles by Vauquelin, G. Search for Related Content PubMed PubMed Citation Articles by Fierens, F. L. Articles by Vauquelin, G. Social Bookmarking                         What's this?

Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists

Department of Molecular and Biochemical Pharmacology, Institute of Molecular Biology and Biotechnology, Free University of Brussels (VUB), B-1640 Sint-Genesius Rode, Belgium, ffierens@ vub.ac.be

Patrick ML Vanderheyden

Department of Molecular and Biochemical Pharmacology, Institute of Molecular Biology and Biotechnology, Free University of Brussels (VUB), B-1640 Sint-Genesius Rode, Belgium

Zsuzsanna Gáborik

Department of Physiology, Semmelweis University Medical School, H-1444 Budapest, PO Box 259, Hungary

Tam Le Minh

Department of Molecular and Biochemical Pharmacology, Institute of Molecular Biology and Biotechnology, Free University of Brussels (VUB), B-1640 Sint-Genesius Rode, Belgium

Jean-Paul De Backer

Department of Molecular and Biochemical Pharmacology, Institute of Molecular Biology and Biotechnology, Free University of Brussels (VUB), B-1640 Sint-Genesius Rode, Belgium

László Hunyady

Department of Physiology, Semmelweis University Medical School, H-1444 Budapest, PO Box 259, Hungary

Adriaan Ijzerman

Division of Medicinal Chemistry, Leiden/Amsterdam Centre of Drug Research, Universiteit Leiden, PO Box 9502, 230 RA Leiden, The Netherlands

Georges Vauquelin

Department of Molecular and Biochemical Pharmacology, Institute of Molecular Biology and Biotechnology, Free University of Brussels (VUB), B-1640 Sint-Genesius Rode, Belgium

Many slow dissociating (insurmountable) non-peptide angiotensin type 1 receptor (AT₁) antagonists contain, besides the acidic biphenyltetrazole substructure of losartan, a second acidic group to stabilise antagonist-receptor complexes. To investigate the involved basic amino-acids of the human AT₁-receptor, wild-type and mutant receptors were transiently transfected in CHO-K1 cells and characterised by [³H]candesartan binding. Lys¹⁹⁹ Gln substitution decreased the affinity 45-fold for candesartan (95% insurmountable), 18-fold for EXP3174 (70% insurmountable), 10-fold for irbesartan (40% insurmountable) and 5-fold for losartan (surmountable). His²⁵⁶ Ala substitution had only minor effects. This suggests that Lys¹⁹⁹ is important for the tight binding of non-peptide antagonists.

Key Words: CHO cells • angiotensin II • human AT1-receptor • mutation • insurmountable non-peptide antagonist

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 3, 283-288 (2000)
DOI: 10.3317/jraas.2000.044


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure Physiol Rev, April 1, 2007; 87(2): 565 - 592. [Abstract] [Full Text] [PDF]

				M. T. Le, P. M. L. Vanderheyden, M. Szaszak, L. Hunyady, and G. Vauquelin Angiotensin IV Is a Potent Agonist for Constitutive Active Human AT1 Receptors. DISTINCT ROLES OF THE N- AND C-TERMINAL RESIDUES OF ANGIOTENSIN II DURING AT1 RECEPTOR ACTIVATION J. Biol. Chem., June 21, 2002; 277(26): 23107 - 23110. [Abstract] [Full Text] [PDF]